Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
J Mol Cell Cardiol ; 82: 84-92, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25771143

RESUMO

Atrial fibrillation (AF) is associated with structural remodeling in atrial myocytes. Emerging evidence suggests that statin has a protective effect on AF through cholesterol-independent mechanisms. The aim of this study is to investigate whether heme oxygenase-1 (HO-1), a potent antioxidant system, mediates the suppressive effect of statin on atrial tachycardia-induced structural remodeling. Treatment of cultured atrium-derived myocytes (HL-1 cell line) with rosuvastatin enhanced HO-1 expression/activity and attenuated tachypacing-induced oxidative stress and myofibril degradation. Heme oxygenase-1 inhibitors and small-interfering RNA for HO-1 blocked the inhibitory effect of rosuvastatin on tachypacing-stimulated changes, suggesting the crucial role of HO-1 in mediating the effect of rosuvastatin. Time-dependent experiments and loss-of-function study demonstrated that Akt/Nrf2 pathways lay to the up-stream of HO-1 in this signaling cascade. Furthermore, the involvement of Akt/Nrf2/HO-1 pathway in the antioxidant effect of rosuvastatin was documented in an ex vivo tachypacing model. The suppressive effect of statin on atrial tachypacing-induced cellular remodeling is mediated via the activation of Akt/Nrf2/HO-1 signaling, which provides a possible explanation for the protective effect of statin on AF.


Assuntos
Heme Oxigenase-1/metabolismo , Inibidores de Hidroximetilglutaril-CoA Redutases/farmacologia , Miócitos Cardíacos/metabolismo , Fator 2 Relacionado a NF-E2/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Rosuvastatina Cálcica/farmacologia , Transdução de Sinais/efeitos dos fármacos , Taquicardia Atrial Ectópica/metabolismo , Animais , Remodelamento Atrial/efeitos dos fármacos , Colágeno/metabolismo , Modelos Animais de Doenças , Ativação Enzimática , Fibroblastos/metabolismo , Expressão Gênica , Heme Oxigenase-1/genética , Masculino , Estresse Oxidativo/efeitos dos fármacos , Fosfatidilinositol 3-Quinases/metabolismo , Ratos , Taquicardia Atrial Ectópica/genética , Taquicardia Atrial Ectópica/patologia
2.
Europace ; 13(5): 747-54, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21297123

RESUMO

AIMS: Rapid atrial pacing for 1 week leads to decreased expression of endocardial nitric oxide (NO)-synthase and decreased NO concentrations. We hypothesized that increasing NO bioavailability may reduce electrical remodelling induced by atrial tachycardia. METHODS AND RESULTS: We examined the effect of molsidomine, a NO donor, and N(ω)-nitro-l-arginine methylester (l-NAME), a NO-synthase inhibitor, on electrical remodelling occurring during 4 h of rapid atrial pacing in sheep. Haemodynamic and electrophysiological parameters were measured at baseline, 1 h after the start of the infusion and before the start of pacing, and 2 and 4 h after pacing. We measured the effect of molsidomine on atrial monophasic action potentials (MAPs) in non-instrumented sheep and on l-type Ca(2+) currents and intracellular Ca(2+) concentration ([Ca(2+)](i)) transients in right atrial cells, isolated from control sheep. In control sheep, rapid atrial pacing shortened the atrial effective refractory period (AERP) by 12 ± 0.18% after 4 h, an effect that was unaffected by l-NAME. Infusion of molsidomine increased AERP at baseline (+13.4 ± 1.04%) and transiently attenuated pacing-induced AERP shortening (13.6 ± 0.1% at 2 h). Molsidomine tended to increase MAP duration by 20.7 ± 13.4 ms. Incubation of isolated atrial myocytes with NO donor 3-morpholino-sydnonimine (SIN-1) increased significantly l-type Ca(2+) current and [Ca(2+)](i) transients. CONCLUSION: Infusion of molsidomine, a NO donor, delayed shortening of the action potential during short-term rapid atrial pacing, by increasing [Ca(2+)](i). Whereas the former could be protective against repetitive short episodes of atrial fibrillation, the latter might be detrimental in the long term.


Assuntos
Sistema de Condução Cardíaco/efeitos dos fármacos , Molsidomina/farmacologia , Doadores de Óxido Nítrico/farmacologia , Óxido Nítrico/metabolismo , Taquicardia Atrial Ectópica , Potenciais de Ação/efeitos dos fármacos , Potenciais de Ação/fisiologia , Animais , Pressão Sanguínea/fisiologia , Cálcio/metabolismo , Canais de Cálcio Tipo L/fisiologia , Estimulação Cardíaca Artificial , Modelos Animais de Doenças , Feminino , Sistema de Condução Cardíaco/fisiologia , Período Refratário Eletrofisiológico/efeitos dos fármacos , Período Refratário Eletrofisiológico/fisiologia , Ovinos , Taquicardia Atrial Ectópica/tratamento farmacológico , Taquicardia Atrial Ectópica/metabolismo , Taquicardia Atrial Ectópica/fisiopatologia
3.
Sci Rep ; 11(1): 11441, 2021 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-34075111

RESUMO

In the last several years, quite a few papers on the joint question of transport, tortuosity and percolation have appeared in the literature, dealing with passage of miscellaneous liquids or electrical currents in different media. However, these methods have not been applied to the passage of action potential in heart fibrosis (HF), which is crucial for problems of heart arrhythmia, especially of atrial tachycardia and fibrillation. In this work we address the HF problem from these aspects. A cellular automaton model is used to analyze percolation and transport of a distributed-fibrosis inflicted heart-like tissue. Although based on a rather simple mathematical model, it leads to several important outcomes: (1) It is shown that, for a single wave front (as the one emanated by the heart's sinus node), the percolation of heart-like matrices is exactly similar to the forest fire case. (2) It is shown that, on the average, the shape of the transport (a question not dealt with in relation to forest fire, and deals with the delay of action potential when passing a fibrotic tissue) behaves like a Gaussian. (3) Moreover, it is shown that close to the percolation threshold the parameters of this Gaussian behave in a critical way. From the physical point of view, these three results are an important contribution to the general percolation investigation. The relevance of our results to cardiological issues, specifically to the question of reentry initiation, are discussed and it is shown that: (A) Without an ectopic source and under a mere sinus node operation, no arrhythmia is generated, and (B) A sufficiently high refractory period could prevent some reentry mechanisms, even in partially fibrotic heart tissue.


Assuntos
Potenciais de Ação , Fibrilação Atrial , Simulação por Computador , Modelos Cardiovasculares , Miocárdio/metabolismo , Animais , Fibrilação Atrial/metabolismo , Fibrilação Atrial/fisiopatologia , Fibrose , Humanos , Taquicardia Atrial Ectópica/metabolismo , Taquicardia Atrial Ectópica/fisiopatologia
4.
Br J Pharmacol ; 152(7): 981-3, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17828293

RESUMO

The common cardiac arrhythmia atrial fibrillation (AF) tends to show progression in its severity, which is associated with 'remodelling': structural and electrophysiological changes that facilitate arrhythmia induction and maintenance. In this issue of the BJP, Yeh and colleagues demonstrate for the first time, down-regulation of three types of muscarinic cholinergic receptor (mAChR) coupled K+ currents (IKM2, IKM3 and IKM4) and of M2, M3 and M4 mAChR subtype proteins, in a canine model of atrial tachycardia (AT) induced remodelling. The IKMs and their extent of AT-induced remodelling were similar in left-atrial and pulmonary vein (PV) myocytes, so remodelling of M2-M4 receptor-linked currents appears not to underlie the unique contribution of PVs to AF. Parasympathetic stimulation can increase susceptibility to AF; thus remodelling of M2-M4 receptors and K+ currents could be adaptive in AT. Further work is warranted to determine whether or not remodelling of multiple mAChRs and currents also contributes to human AF.


Assuntos
Fibrilação Atrial/metabolismo , Canais de Potássio Corretores do Fluxo de Internalização/metabolismo , Receptores Muscarínicos/metabolismo , Animais , Fibrilação Atrial/fisiopatologia , Modelos Animais de Doenças , Regulação para Baixo , Humanos , Taquicardia Atrial Ectópica/metabolismo , Taquicardia Atrial Ectópica/fisiopatologia
5.
Br J Pharmacol ; 152(7): 1021-32, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17618308

RESUMO

BACKGROUND AND PURPOSE: Both parasympathetic tone and atrial tachycardia (AT) remodelling of ion channels play important roles in atrial fibrillation (AF) pathophysiology. Different muscarinic cholinergic receptor (mAChR) subtypes (M2, M3, M4) in atrial cardiomyocytes are coupled to distinct K+-currents (called IKM2, IKM3, IKM4, respectively). Pulmonary veins (PVs) are important in AF and differential cholinergic current responses are a potential underlying mechanism. This study investigated AT-induced remodelling of mAChR subtypes and K+-currents in left-atrial (LA) and PV cardiomyocytes. EXPERIMENTAL APPROACH: Receptor expression was assayed by western blot. IKM2, IKM3 and IKM4 were recorded with whole-cell patch-clamp in LA and PV cardiomyocytes of nonpaced control dogs and dogs after 7 days of AT-pacing (400 bpm). KEY RESULTS: Current densities of IKM2, IKM3 and IKM4 were significantly reduced by AT-pacing in LA and PV cardiomyocytes. PV cardiomyocyte current-voltage relations were similar to LA for all three cholinergic currents, both in control and AT remodelling. Membrane-protein expression levels corresponding to M2, M3 and M4 subtypes were decreased significantly (by about 50%) after AT pacing. Agonist concentration-response relations for all three currents were unaffected by AT pacing. CONCLUSIONS AND IMPLICATIONS: AT downregulated all three mAChR-coupled K+-current subtypes, along with corresponding mAChR protein expression. These changes in cholinergic receptor-coupled function may play a role in AF pathophysiology. Cholinergic receptor-coupled K+-currents in PV cardiomyocytes were similar to those in LA under control and AT-pacing conditions, suggesting that differential cholinergic current properties do not explain the role of PVs in AF.


Assuntos
Átrios do Coração/metabolismo , Miócitos Cardíacos/metabolismo , Canais de Potássio Corretores do Fluxo de Internalização/metabolismo , Veias Pulmonares/metabolismo , Receptores Muscarínicos/metabolismo , Taquicardia Atrial Ectópica/metabolismo , Animais , Fibrilação Atrial/metabolismo , Fibrilação Atrial/fisiopatologia , Western Blotting , Estimulação Cardíaca Artificial , Células Cultivadas , Modelos Animais de Doenças , Cães , Regulação para Baixo , Técnicas Eletrofisiológicas Cardíacas , Potenciais Evocados , Átrios do Coração/patologia , Miócitos Cardíacos/patologia , Técnicas de Patch-Clamp , Veias Pulmonares/patologia , Receptores Muscarínicos/biossíntese , Taquicardia Atrial Ectópica/fisiopatologia , Fatores de Tempo
6.
Resuscitation ; 70(3): 423-31, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16901614

RESUMO

BACKGROUND: Electrical cardioversion in patients with various types of supraventricular tachyarrhythmia (SVT) may induce serum cardiac markers elevation. Only a few studies have evaluated the impact of the type of shock waveform on electrical myocardial injury. The aim of our study was to compare the response of serum cardiac markers to biphasic and monophasic cardioversion for SVT. METHODS: One hundred and forty one patients with various SVTs referred for electrical cardioversion were randomised to monophasic (MP) or biphasic (BP) cardioversion. Serum levels of creatine kinase (CK), MB fraction of CK (CK-MB), myoglobin and troponin I were analysed before cardioversion and 254+/-58 min after the procedure. RESULTS: Average age of the patients was 67.9+/-11.3 years, 71 underwent BP and 70 MP cardioversion. In MP group, cumulative energy (CE)>150J was associated with significant elevation of CK and myoglobin levels after cardioversion (1.52+/-3.81 microkat/l and 187+/-433 microg/l), while CE<150J was not (-0.04+/-0.34 and 4+/-11, p<0.05). In BP group, CE>150J was associated with significant but smaller CK elevation (0.27+/-1.09 microkat/l, p<0.05) and comparable myoglobin elevation (80.7+/-21.4 microg/l, p<0.05). CE>150J was the only independent positive predictor for CK and myoglobin elevation in both groups. No significant changes in CK-MB and Troponin I levels after cardioversion were identified. CONCLUSIONS: According to our study, electrical cardioversion for SVTs is not associated with biochemical signs of myocardial injury. Application of CE>150J can be followed by CK and myoglobin elevation most likely due to skeletal muscle damage. This reaction is more pronounced in MP than in BP cardioversion.


Assuntos
Biomarcadores/sangue , Cardioversão Elétrica/métodos , Taquicardia Supraventricular/sangue , Taquicardia Supraventricular/terapia , Fibrilação Atrial/sangue , Fibrilação Atrial/metabolismo , Fibrilação Atrial/terapia , Flutter Atrial/sangue , Flutter Atrial/metabolismo , Flutter Atrial/terapia , Humanos , Taquicardia Atrial Ectópica/sangue , Taquicardia Atrial Ectópica/metabolismo , Taquicardia Atrial Ectópica/terapia , Taquicardia Supraventricular/metabolismo
7.
Pharmacotherapy ; 24(7): 879-95, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15303452

RESUMO

Atrial tachyarrhythmias, including atrial fibrillation and flutter, occur frequently. Magnesium has been studied in the early conversion and prevention of atrial tachyarrhythmias, as well as in prevention of atrial tachyarrhythmias after coronary artery bypass graft surgery. Early conversion of atrial tachyarrhythmias and control of heart rate may be greater with magnesium than with common antiarrhythmic agents. Magnesium appears to be less useful for preventing recurrent atrial tachyarrhythmias; however, discrepancies in study methodologies make interpretation of results difficult. The use of magnesium for prevention of postoperative atrial arrhythmias has produced conflicting results, likely due to differences in study design. From the limited data available, magnesium appears to have some inherent antiarrhythmic properties. Certain patient populations may derive benefit from magnesium for the treatment of atrial tachyarrhythmias. However, further study is necessary to define the role of magnesium clearly for the treatment or prevention of atrial tachyarrhythmias.


Assuntos
Magnésio/uso terapêutico , Taquicardia Atrial Ectópica/tratamento farmacológico , Humanos , Magnésio/metabolismo , Deficiência de Magnésio/tratamento farmacológico , Deficiência de Magnésio/metabolismo , Taquicardia Atrial Ectópica/metabolismo
9.
Am J Physiol Heart Circ Physiol ; 295(2): H691-8, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18539751

RESUMO

The purpose of the present study was to determine whether thoracic veins may act as ectopic pacemakers and whether nodelike cells and rich sympathetic innervation are present at the ectopic sites. We used a 1,792-electrode mapping system with 1-mm resolution to map ectopic atrial arrhythmias in eight normal dogs during in vivo right and left stellate ganglia (SG) stimulation before and after sinus node crushing. SG stimulation triggered significant elevations of transcardiac norepinephrine levels, sinus tachycardia in all dogs, and atrial tachycardia in two of eight dogs. Sinus node crushing resulted in a slow junctional rhythm (51 +/- 6 beats/min). Subsequent SG stimulation induced 20 episodes of ectopic beats in seven dogs and seven episodes of pulmonary vein tachycardia in three dogs (cycle length 273 +/- 35 ms, duration 16 +/- 4 s). The ectopic beats arose from the pulmonary vein (n = 11), right atrium (n = 5), left atrium (n = 2), and the vein of Marshall (n = 2). There was no difference in arrhythmogenic effects of left vs. right SG stimulation (13/29 vs. 16/29 episodes, P = nonsignificant). There was a greater density of periodic acid Schiff-positive cells (P < 0.05) and sympathetic nerves (P < 0.05) at the ectopic sites compared with other nonectopic atrial sites. We conclude that, in the absence of a sinus node, thoracic veins may function as subsidiary pacemakers under heightened sympathetic tone, becoming the dominant sites of initiation of focal atrial arrhythmias that arise from sites with abundant sympathetic nerves and periodic acid Schiff-positive cells.


Assuntos
Relógios Biológicos , Estimulação Elétrica , Gânglio Estrelado/fisiopatologia , Fibras Simpáticas Pós-Ganglionares/fisiopatologia , Taquicardia Atrial Ectópica/fisiopatologia , Taquicardia Sinusal/fisiopatologia , Tórax/irrigação sanguínea , Animais , Mapeamento Potencial de Superfície Corporal , Cães , Epinefrina/sangue , Interpretação de Imagem Assistida por Computador , Norepinefrina/sangue , Reação do Ácido Periódico de Schiff , Veias Pulmonares/inervação , Veias Pulmonares/fisiopatologia , Nó Sinoatrial/fisiopatologia , Fibras Simpáticas Pós-Ganglionares/metabolismo , Taquicardia Atrial Ectópica/metabolismo , Taquicardia Atrial Ectópica/patologia , Taquicardia Sinusal/metabolismo , Taquicardia Sinusal/patologia , Fatores de Tempo , Veias/inervação , Veias/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA